What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- COPD
Jean Bourbeau focuses on COPD, Physical therapy, Intensive care medicine, Exacerbation and Randomized controlled trial.
His COPD research is classified as research in Internal medicine.
Jean Bourbeau mostly deals with Pulmonary rehabilitation in his studies of Physical therapy.
Jean Bourbeau has included themes like Smoking cessation, Guideline, Obstructive lung disease, Spirometry and Comorbidity in his Intensive care medicine study.
His Exacerbation research is multidisciplinary, relying on both Anesthesia, Prospective cohort study and Medical prescription.
His Randomized controlled trial research incorporates elements of Pharmacotherapy and Emergency medicine.
His most cited work include:
- An official American thoracic society/European respiratory society statement: Key concepts and advances in pulmonary rehabilitation (1658 citations)
- American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation (1460 citations)
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary (1253 citations)
What are the main themes of his work throughout his whole career to date?
Jean Bourbeau mainly focuses on COPD, Physical therapy, Internal medicine, Intensive care medicine and Pulmonary disease.
Jean Bourbeau combines subjects such as Exacerbation, Randomized controlled trial and Spirometry with his study of COPD.
His Exacerbation study integrates concerns from other disciplines, such as Medical prescription and Pediatrics.
His research investigates the link between Physical therapy and topics such as Placebo that cross with problems in Anesthesia.
His Internal medicine study frequently draws connections to adjacent fields such as Cardiology.
His Intensive care medicine study combines topics in areas such as Psychological intervention, Disease management, Disease and Quality of life.
He most often published in these fields:
- COPD (73.32%)
- Physical therapy (32.29%)
- Internal medicine (30.04%)
What were the highlights of his more recent work (between 2018-2021)?
- COPD (73.32%)
- Pulmonary disease (24.22%)
- Internal medicine (30.04%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are COPD, Pulmonary disease, Internal medicine, Intensive care medicine and Obstructive lung disease.
His COPD study combines topics from a wide range of disciplines, such as Exacerbation, Physical therapy, Quality of life and Asthma.
His Physical therapy research incorporates themes from Olodaterol and Metabolic demand.
His studies deal with areas such as Blood eosinophils, Disease, Gerontology and Computed tomography as well as Pulmonary disease.
His Internal medicine research includes elements of Gastroenterology and Cardiology.
His Intensive care medicine study incorporates themes from Pharmacotherapy and Pharmacological therapy.
Between 2018 and 2021, his most popular works were:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 (472 citations)
- Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease (47 citations)
- Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report (27 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- COPD
COPD, Pulmonary disease, Intensive care medicine, Internal medicine and Obstructive lung disease are his primary areas of study.
His research in COPD intersects with topics in Psychological intervention, Exacerbation, Physical therapy and Pharmacotherapy.
His work carried out in the field of Pulmonary disease brings together such families of science as Health equity, Disease progression, Evidence-based medicine and Gerontology.
His work deals with themes such as Precision medicine and Nicotine, which intersect with Intensive care medicine.
His study explores the link between Internal medicine and topics such as Cardiology that cross with problems in Airflow obstruction, Nocturnal, Intention-to-treat analysis and Oxygen therapy.
The various areas that Jean Bourbeau examines in his Obstructive lung disease study include Hazard ratio, Lung volumes, Rate ratio, Vaccination and Global health.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
